Canadian Medical Center H1 2024 profit down 58% to SAR 3.4M

Canadian Medical Center H1 2024 profit down 58% to SAR 3.4M

21/08/2024 Argaam Exclusive

View other reports

Canadian Medical Center Co. reported a net profit of SAR 3.4 million for H1 2024, down 58% from SAR 8 million a year earlier due to its transformation project.



Financials (M)

Item 6m 2023 6m 2024 Change‬
Revenues 45.22 51.22 13.3 %
Gross Income 14.21 11.51 (19.0 %)
Operating Income 8.31 3.88 (53.3 %)
Net Income 8.00 3.37 (57.9 %)
Average Shares 77.00 77.00 -
EPS (Riyals) 0.10 0.04 (57.9 %)


Current Half Annual Comparison (M)

Compared With The
Item H1 2023 H1 2024 Change‬
Revenues 45.22 51.22 13.3 %
Gross Income 14.21 11.51 (19.0 %)
Operating Income 8.31 3.88 (53.3 %)
Net Income 8.00 3.37 (57.9 %)
Average Shares 77.00 77.00 -
EPS (Riyals) 0.10 0.04 (57.9 %)

Revenue increased by 13.3% year-on-year to SAR 51.22 million, driven by the company’s expansion and growth strategy, including opening new branches in promising and more profitable areas and sectors.

 

Total shareholders’ equity, no minority interest, fell to SAR 88.05 million by June 30, 2024, compared to SAR 90.75 million a year ago.

 

Historical Development of Semi-Annual Data

Period

Revenue 

(SAR mln)

Net Profit

(SAR mln)

Earnings Per Share

(SAR)​

H1 2020

29.83

8.4

0.11

H2 2020

34.38

7.75

0.10

H1 2021

30.18

4.96

0.06

H2 2021

40.46

9.1

0.12

H1 2022

38.92

7.94

0.10

H2 2022

42.31

7.71

0.10

H1 2023

45.22

8.00

0.10

H2 2023

55.12

7.71

0.10

H1 2024

51.22

3.36

0.04
 

View More Financial Results

 


Financial results (Million)

Period Revenues Change Gross Income Change Operating Income Change
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 29.83 - 12.22 - 8.72 -
H2 2020 34.38 - 11.80 - 8.44 -
H1 2021 30.18 1.2 % 12.39 1.4 % 6.51 (25.4 %)
H2 2021 40.46 17.7 % 12.80 8.4 % 9.80 16.0 %
H1 2022 38.92 28.9 % 12.63 1.9 % 9.11 40.1 %
H2 2022 42.31 4.6 % 12.34 (3.6 %) 8.15 (16.9 %)
H1 2023 45.22 16.2 % 14.21 12.5 % 8.31 (8.8 %)
H2 2023 55.13 30.3 % 17.33 40.4 % 7.59 (6.8 %)
H1 2024 51.22 13.3 % 11.51 (19.0 %) 3.88 (53.3 %)


Profit Performance (Million)

Period Net Income Change EPS(Riyal) Extraordinary Income/Expense Net Profit Before Unusual Items EPS Before XO Items
H1 2015 - - - - - -
H2 2015 - - - - - -
H1 2016 - - - - - -
H2 2016 - - - - - -
H1 2017 - - - - - -
H2 2017 - - - - - -
H1 2018 - - - - - -
H2 2018 - - - - - -
H1 2019 - - - - - -
H2 2019 - - - - - -
H1 2020 8.40 - 0.11 - 8.40 0.11
H2 2020 7.75 - 0.10 - 7.75 0.10
H1 2021 4.96 (40.9 %) 0.06 - 4.96 0.06
H2 2021 9.10 17.4 % 0.12 - 9.10 0.12
H1 2022 7.94 59.9 % 0.10 - 7.94 0.10
H2 2022 7.72 (15.2 %) 0.10 - 7.72 0.10
H1 2023 8.00 0.8 % 0.10 - 8.00 0.10
H2 2023 7.71 (0.1 %) 0.10 - 7.71 0.10
H1 2024 3.37 (57.9 %) 0.04 - 3.37 0.04

Profitability

Period Gross Margin OIBDA Margin Net Margin Before Unusual Items
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 37.42 % 31.13 % 25.15 %
H1 2021 37.48 % 28.00 % 19.70 %
H2 2021 35.66 % 27.24 % 19.91 %
H1 2022 32.04 % 27.32 % 21.47 %
H2 2022 30.74 % 25.12 % 19.27 %
H1 2023 30.34 % 22.31 % 17.96 %
H2 2023 31.43 % 17.57 % 15.66 %
H1 2024 27.12 % 12.95 % 10.42 %


Per Share Data (Riyal)

Compared With The
Period Shares Outstanding (M) EPS (Riyal) Adjusted EPS (Riyal) Book Value (BV)
H1 2015 - - - -
H2 2015 - - - -
H1 2016 - - - -
H2 2016 - - - -
H1 2017 - - - -
H2 2017 - - - -
H1 2018 - - - -
H2 2018 - - - -
H1 2019 - - - -
H2 2019 - - - -
H1 2020 77.00 - - 0.19
H2 2020 77.00 0.21 0.21 1.20
H1 2021 77.00 0.17 0.17 1.26
H2 2021 77.00 0.18 0.18 1.23
H1 2022 77.00 0.22 0.22 1.18
H2 2022 77.00 0.20 0.20 1.13
H1 2023 77.00 0.20 0.20 1.18
H2 2023 77.00 0.20 0.20 1.19
H1 2024 77.00 0.14 0.14 1.14

Multiple Ratios (End of Period Price)

Compared With The
Period P/E Adjusted P/E Price/book
H1 2015 - - -
H2 2015 - - -
H1 2016 - - -
H2 2016 - - -
H1 2017 - - -
H2 2017 - - -
H1 2018 - - -
H2 2018 - - -
H1 2019 - - -
H2 2019 - - -
H1 2020 - - -
H2 2020 - - -
H1 2021 - - -
H2 2021 47.36 47.36 7.05
H1 2022 22.96 22.96 4.32
H2 2022 22.13 22.13 3.98
H1 2023 27.97 27.97 4.84
H2 2023 28.62 28.62 4.90
H1 2024 45.31 45.31 5.70

Business Segments (Million)

Compared With The
Period Medical Clinics Sector Medical Clinics Project Contracts Sector


Share Price

Canadian Medical Center Co.
7.00
0.02 0.29 %

Canadian Medical Center Co. (CMCER)

More

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.